The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages.
Lancet Infect Dis
; 22(12): 1665-1666, 2022 Dec.
Article
in English
| MEDLINE | ID: covidwho-2150860
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccines
/
COVID-19
Type of study:
Experimental Studies
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Lancet Infect Dis
Journal subject:
Communicable Diseases
Year:
2022
Document Type:
Article
Affiliation country:
S1473-3099(22)00693-4
Similar
MEDLINE
...
LILACS
LIS